Enliven Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$48.72

-0.15 (-0.31%)

As of Sep 22, 1:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -35.0% upside

Low Target $20.91

Average Target $31.67

High Target $36.06

Current Price $48.72

Current
$48.72

Target
$31.67

$20.91 $31.67 avg $36.06

Scenario Analysis

Bear Case

$20.91

-57.1%

Low target

Base Case

$31.67

-35.0%

Avg target

Bull Case

$36.06

+-26.0%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$62.32

-21.8% from high

52-Week Low

$14.79

+229.5% from low

Target vs 52W High

$31.67

-49.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%